1-16 of 16
Challice L. Bonifant
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Proteomics Analysis Identifies Candidate Biomarkers for Prediction of Post-CAR-T Cytopenias

Rashmi Madhukar, Christopher Flora, Mary Olesnavich, Erin Sandford, Michelle Rozwadowski, Gen Li, Marcus Johannes Geer, Gregory Yanik, Monalisa Ghosh, David Frame, Jennifer Elise Agrusa, Challice L. Bonifant, Tania Jain, Sung W. Choi, Muneesh Tewari
Journal: Blood
Blood (2024) 144 (Supplement 1): 7168.
https://doi.org/10.1182/blood-2024-211453
Published: 2024
Journal Articles

Role of B Cell Recovery in Relapse Risk and CD19 Phenotype Following Real-World Use of Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia: A Multi-Institutional Retrospective Study

Xiaopei Lily Zeng, Soyang Kwon, Anant Vatsayan, Christina Baggott, Snehit Prabhu, Samuel John, Holly L. Pacenta, Christine L. Phillips, Jenna Rossoff, Julie-An Talano, Amy Moskop, Michael R Verneris, Douglas D. Myers, Erin Marie Hall, Nicole A Karras, Challice L. Bonifant, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K Keating, Susanne H.C. Baumeister, Vanessa A. Fabrizio, Vasant Chinnabhandar, Emily Egeler, Sharon Mavroukakis, Khanh Nguyen, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora Michal Schultz, Kevin O. McNerney
Journal: Blood
Blood (2024) 144 (Supplement 1): 2817.
https://doi.org/10.1182/blood-2024-211231
Published: 2024
Journal Articles

A Phase IB/II Study of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or Marrow Transplant (alloBMT) Remission Maintenance

Jonathan Allen Webster, Richard J. Jones, Amanda Blackford, Audra Shedeck, Richard F. Ambinder, Lode J. Swinnen, Nina Wagner-Johnston, Ephraim Joseph Fuchs, Javier Bolanos-Meade, Philip Imus, Challice L. Bonifant, Heather Jill Symons, Tania Jain, Gabrielle T. Prince, Mark J. Levis, Leo Luznik, Ivana Gojo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3582.
https://doi.org/10.1182/blood-2023-191047
Published: 2023
Journal Articles

Risk Factors and Outcomes for Hematotoxicity Following Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia

Kevin O. McNerney, Vanessa A. Fabrizio, Aimee C. Talleur, Stephanie Si Lim, Alexandra Dreyzin, Christina Baggott, Anant Vatsayan, Jenna Rossoff, Snehit Prabhu, Holly L. Pacenta, Christine L Phillips, Julie-An Talano, Amy Moskop, Michael R Verneris, Douglas Myers, Nicole Karras, Challice L. Bonifant, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy Keating, Susanne H.C. Baumeister, Vasant Chinnabhandar, Emily Egeler, Kevin J Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora Michal Schultz, Swati Naik
Journal: Blood
Blood (2023) 142 (Supplement 1): 2133.
https://doi.org/10.1182/blood-2023-189921
Published: 2023
Journal Articles

CD4+/CD8+ Selection of Anti-AML ENG-T Cells Affects Long-Term T-Cell Persistence in Vitro and Survival in an AML Xenograft Model

Natalie J. Holl, Adam Fearnow, Stamatia C. Vorri, Ruyan Rahnama, Ilias Christodoulou, Jun Choe, Alokesh Ghosal, Cynthia Ng, Arjun Modi, Vinay Vyas, Challice L. Bonifant
Journal: Blood
Blood (2023) 142 (Supplement 1): 1038.
https://doi.org/10.1182/blood-2023-189840
Published: 2023
Journal Articles

Engineering builds multipotency for iPSC-NKs

Ruyan Rahnama, Challice L. Bonifant
Journal: Blood
Blood (2022) 140 (23): 2414–2416.
https://doi.org/10.1182/blood.2022017794
Published: 2022
Journal Articles

CAR-NK Cells Targeting Sars-Cov-2 Glycosites As COVID-19 Treatment

Ilias Christodoulou, Ruyan Rahnama, Wesley J. Ravich, Jaesung Seo, Sergey Zolov, Andrew Marple, David M Markovitz, Challice L. Bonifant
Journal: Blood
Blood (2021) 138 (Supplement 1): 2803.
https://doi.org/10.1182/blood-2021-146865
Published: 2021
Journal Articles

Engineered Interleukin-15 Autocrine Signaling Invigorates Anti-CD123 CAR-NK Cells

Ilias Christodoulou, Michael Koldobskiy, Won Jin Ho, Andrew Marple, Wesley J. Ravich, Ruyan Rahnama, Challice L. Bonifant
Journal: Blood
Blood (2021) 138 (Supplement 1): 2806.
https://doi.org/10.1182/blood-2021-146609
Published: 2021
Journal Articles

Venetoclax Enhances Anti-Leukemia Activity of CD123-Specific BiTE-Secreting T-Cells in AML

Hong Mu-Mosley, MDPhD, Lauren B Ostermann, BS, Ran Zhao, BS, Challice L. Bonifant, MDPhD, Stephen Gottschalk, MD, Mireya Paulina Velasquez, MD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-139625
Published: 2020
Journal Articles

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells

Abishek Vaidya, MS, Erin E Doherty, MD, Xiya Wu, Challice L. Bonifant, MD PhD, Stephen Gottschalk, MD, Mireya Paulina Velasquez, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4441.
https://doi.org/10.1182/blood-2019-125395
Published: 2019
Journal Articles

Transgenic Expression of IL15 in CD123-Specific BiTE-Secreting Engager T-Cells Results in Improved Anti-AML Activity

Hong Mu-Mosley, MD PhD, Lauren B Ostermann, Muharrem Muftuoglu, MD, Wendy Schober, Nalini B Patel, Abishek Vaidya, MS, Challice L. Bonifant, MD PhD, Stephen Gottschalk, MD, Mireya Paulina Velasquez, MD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3917.
https://doi.org/10.1182/blood-2019-125928
Published: 2019
Journal Articles

Myd88/CD40 Costimulation to Enhance the Antitumor Activity of CD123-ENG T-Cells for the Immunotherapy of AML

Erin Doherty, MD, Abishek Vaidya, MS, Xiya Wu, Challice L. Bonifant, MD PhD, Melinda Mata, PhD, Ann M. Leen, PhD, Stephen Gottschalk, MD, Mireya P. Velasquez, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4075.
https://doi.org/10.1182/blood-2018-99-116817
Published: 2018
Journal Articles

IL15 Expressing CD123-Targeted Engager T-Cell Therapy for Adult Acute Myeloid Leukemia

Hong Mu, MD PhD, Huaxian Ma, MS, Abishek Vaidya, MS, Challice L. Bonifant, MD PhD, Stephen Gottschalk, MD, Mireya P. Velasquez, MD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2724.
https://doi.org/10.1182/blood-2018-99-116811
Published: 2018
Journal Articles

Redirecting T cells to hematological malignancies with bispecific antibodies

Mireya Paulina Velasquez, Challice L. Bonifant, Stephen Gottschalk
Journal: Blood
Blood (2018) 131 (1): 30–38.
https://doi.org/10.1182/blood-2017-06-741058
Published: 2018
Journal Articles

Two-Pronged Cell Therapy for B-Cell Malignancies: Engineering NK Cells to Target CD22 and Redirect Bystander T Cells to CD19

Mireya Paulina Velasquez, MD, Arpad Szoor, MD PhD, Challice L. Bonifant, MD PhD, Abishek Vaidya, Lorenzo Brunetti, MD, Michael C Gundry, BS, Robin Parihar, MD PhD, Margaret Goodell, PhD, Stephen Gottschalk, MD
Journal: Blood
Blood (2016) 128 (22): 4560.
https://doi.org/10.1182/blood.V128.22.4560.4560
Published: 2016
Journal Articles

CD123-Engager T Cells As a Novel Immunotherapeutic for AML

Challice L. Bonifant, MD PhD, David Torres, Mireya Paulina Velasquez, MD, Kota Iwahori, MD, Caroline Arber, MD, Xiao-Tong Song, PhD, Michele S. Redell, MD PhD, Stephen Gottschalk, MD
Journal: Blood
Blood (2014) 124 (21): 3762.
https://doi.org/10.1182/blood.V124.21.3762.3762
Published: 2014